A clinical overview of monoamine oxidase inhibitors (Q39819004)

14 September 2017

1 reference

title

A clinical overview of monoamine oxidase inhibitors (English)

1 reference

14 September 2017

Zisook S

1 reference

14 September 2017

publication date

1 March 1985

1 reference

14 September 2017

1 reference

14 September 2017

1 reference

14 September 2017

1 reference

14 September 2017

page(s)

240-6, 251

1 reference

DIFFERENTIAL RESPONSE OF HOSPITALIZED DEPRESSED PATIENTS TO SOMATIC THERAPY

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

Effects of iproniazid in depressive syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

Drugs in the Treatment of Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

Monoamine oxidase inhibitors. A review of antidepressant effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

A multiple-dose, controlled study of phenelzine in depression-anxiety states

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

A double-blind study of tranylcypromine treatment of major anergic depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

Isocarboxazid in the treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

Relationship between Response to Phenelzine and MAO Inhibition in a Clinical Trial of Phenelzine, Amitriptyline and Placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

Response to phenelzine and amitriptyline in subtypes of outpatient depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

Phenelzine and amitriptyline: effects on symptoms of neurotic depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

Phenelzine and amitriptyline in the treatment of depression. A comparison of present and past studies

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

Phenelzine v imipramine in atypical depression. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

Towards Rational Therapy with Monoamine Oxidase Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

Behaviour Therapy versus Drug Therapy in the Treatment of Phobic Neurosis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

Treatment of bulimia with monoamine oxidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

Treatment of traumatic war neurosis with phenelzine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

Monoamine oxidase inhibitors: prescription and patient management

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

Treatment of melancholia with tranylcypromine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

Monoamine oxidase inhibitors in bipolar endogenous depressives

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

1 reference

7 January 2021

The nonmelancholic depressive syndromes. An alternate approach to classification

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

Clinical Pharmacology of Phenelzine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

REM sleep and central monoamine oxidase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

Reversal by bethanechol of sexual dysfunction caused by anticholinergic antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

1 reference

7 January 2021

Propranolol as an antiarrhythmic agent.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

Effect of monoamine oxidase inhibitors on the n-demethylation and hydrolysis of meperidine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

A Study of Refractory Cases of Depressive Illnesses and their Response to Combined Antidepressant Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

The safety and efficacy of combined amitriptyline and tranylcypromine antidepressant treatment. A controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2885%2972877-0

7 January 2021

10.1016/S0033-3182(85)72877-0

Identifiers

DOI

0 references

1 reference